- Introduction to the integrity crisis in medical research and actions to address this to date
- The importance of individual participant data to identify integrity issues
- The Individual Participant Data (IPD) Integrity Tool: What is it? How and when can it be used?
- Future directions, questions, and comments
Presenters
Sol Libesman specializes in advancing the methods and models used in individual participant data meta-analysis and network meta-analysis. His clinical research focuses on cord management at preterm birth, strategies for preventing childhood obesity, eating disorders, and breast cancer screening.
Kylie Hunter is a Research Fellow and co-lead of the NextGen Evidence Synthesis Team at the NHMRC Clinical Trials Centre, University of Sydney. Her research centres on advancing evidence synthesis methods to address high-priority health research questions, with a particular focus on individual participant data, prospective meta-analysis, and research integrity. Kylie led development of the IPD Integrity Tool as part of her PhD.
Latest Resources
-
-
STInG Chat – What makes this trial great?
-
Platform trials: key features, when to use them and methodological challenges
-
Interim Data Sharing by Data Safety Monitoring Board: What to share, with whom, and why
-
Data Integrity Tool for assessing the integrity of randomised trials
-
The value of getting involved with ACTA STInG
-
Winner of the ACTA STInG Excellence in Trial Statistics award shares how ACTA STInG provided valuable networking opportunities during the pandemic
-
Data and Safety Monitoring Board (DSMB) Mentoring Program
-
ACTA Webinar – Developing a Best Practice Guide for Registry Based Trials
Latest Events
-
STInG Chat – What makes this trial great?
-
ACTA 2025 Clinical Trials and Registries Symposium
-
ACTA Webinar – Developing a Best Practice Guide for Registry Based Trials
-
STInG Chat – How to build a career as a clinical trials biostatistician
-
Good Statistical Practice – GCP training for statisticians
-
ACTA – Historical and non-concurrent controls in clinical trials
-
STInG Chat: ‘Securing Funding: Tips and Tricks for Investigator Grants’